Cost-effectiveness analyses of genetic and genomic diagnostic tests
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cost-effectiveness analyses of genetic and genomic diagnostic tests
Authors
Keywords
-
Journal
NATURE REVIEWS GENETICS
Volume 19, Issue 4, Pages 235-246
Publisher
Springer Nature
Online
2018-01-22
DOI
10.1038/nrg.2017.108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Using Cost-Effectiveness Analysis to Quantify the Value of Genomic-Based Diagnostic Tests: Recommendations for Practice and Research
- (2017) Eldon Spackman et al. Genetic Testing and Molecular Biomarkers
- Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement
- (2017) Zornitza Stark et al. GENETICS IN MEDICINE
- Cost-effectiveness of precision medicine in the fourth-line treatment of metastatic lung adenocarcinoma: An early decision analytic model of multiplex targeted sequencing
- (2017) Brett Doble et al. LUNG CANCER
- Evolving health care through personal genomics
- (2017) Heidi L. Rehm NATURE REVIEWS GENETICS
- Discrete Event Simulation-Based Resource Modelling in Health Technology Assessment
- (2017) Syed Salleh et al. PHARMACOECONOMICS
- Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis
- (2017) James Buchanan et al. PHARMACOECONOMICS
- Are Quality-Adjusted Life Years a Good Proxy Measure of Individual Capabilities?
- (2017) Paul Mark Mitchell et al. PHARMACOECONOMICS
- Using Mathematical Optimisation In Model-Based Cost-Effectiveness Analyses: A Case Study Of A Stratified Breast Screening Programme
- (2017) A Donten et al. VALUE IN HEALTH
- Evaluation of a Stratified National Breast Screening Program in the United Kingdom: An Early Model-Based Cost-Effectiveness Analysis
- (2017) Ewan Gray et al. VALUE IN HEALTH
- The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers
- (2017) Deirdre Weymann et al. Molecular Genetics & Genomic Medicine
- Personalized medicine in diabetes: the role of ‘omics’ and biomarkers
- (2016) E. R. Pearson DIABETIC MEDICINE
- A microcosting study of immunogenicity and tumour necrosis factor alpha inhibitor drug level tests for therapeutic drug monitoring in clinical practice
- (2016) Meghna Jani et al. RHEUMATOLOGY
- Welfarism Versus Extra-Welfarism: Can the Choice of Economic Evaluation Approach Impact on the Adoption Decisions Recommended by Economic Evaluation Studies?
- (2015) James Buchanan et al. PHARMACOECONOMICS
- Assessing sufficient capability: A new approach to economic evaluation
- (2015) Paul Mark Mitchell et al. SOCIAL SCIENCE & MEDICINE
- Is the ``$1000 Genome'' really $1000? Understanding the full benefits and costs of genomic sequencing
- (2015) Kathryn A. Phillips et al. TECHNOLOGY AND HEALTH CARE
- The cost-effectiveness of returning incidental findings from next-generation genomic sequencing
- (2014) Caroline S. Bennette et al. GENETICS IN MEDICINE
- The Value of Heterogeneity for Cost-Effectiveness Subgroup Analysis
- (2014) Manuel A. Espinoza et al. MEDICAL DECISION MAKING
- Concepts of ‘Personalization’ in Personalized Medicine: Implications for Economic Evaluation
- (2014) Wolf Rogowski et al. PHARMACOECONOMICS
- Cost-Effectiveness and Harm-Benefit Analyses of Risk-Based Screening Strategies for Breast Cancer
- (2014) Ester Vilaprinyo et al. PLoS One
- The Cost-Effectiveness of a Pharmacogenetic Test: A Trial-Based Evaluation of TPMT Genotyping for Azathioprine
- (2014) Alexander J. Thompson et al. VALUE IN HEALTH
- Appropriate Evidence Sources for Populating Decision Analytic Models within Health Technology Assessment (HTA)
- (2013) Ingrid Zechmeister-Koss et al. MEDICAL DECISION MAKING
- Issues surrounding the health economic evaluation of genomic technologies
- (2013) James Buchanan et al. PHARMACOGENOMICS
- Current Methodological Issues in the Economic Assessment of Personalized Medicine
- (2013) Lieven Annemans et al. VALUE IN HEALTH
- Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force
- (2013) Sean D. Sullivan et al. VALUE IN HEALTH
- VALUING THE ECONOMIC BENEFITS OF COMPLEX INTERVENTIONS: WHEN MAXIMISING HEALTH IS NOT SUFFICIENT
- (2012) Katherine Payne et al. HEALTH ECONOMICS
- Evidence Synthesis for Decision Making 2
- (2012) Sofia Dias et al. MEDICAL DECISION MAKING
- Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6
- (2012) Andrew H. Briggs et al. VALUE IN HEALTH
- Conceptualizing a Model: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2
- (2012) Mark Roberts et al. VALUE IN HEALTH
- State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3
- (2012) Uwe Siebert et al. VALUE IN HEALTH
- Modeling using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4
- (2012) Jonathan Karnon et al. VALUE IN HEALTH
- Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7
- (2012) David M. Eddy et al. VALUE IN HEALTH
- COST-MINIMISATION ANALYSIS VERSUS COST-EFFECTIVENESS ANALYSIS, REVISITED
- (2011) Helen Dakin et al. HEALTH ECONOMICS
- A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study
- (2011) William G Newman et al. PHARMACOGENOMICS
- The $1,000 genome, the $100,000 analysis?
- (2010) Elaine R Mardis Genome Medicine
- Evaluating the utility of personal genomic information
- (2009) Morris W Foster et al. GENETICS IN MEDICINE
- Fish and chips all round? Regulation of DNA-based genetic diagnostics
- (2009) Katherine Payne HEALTH ECONOMICS
- Genomics Research: World Survey of Public Funding
- (2008) Jennifer Pohlhaus et al. BMC GENOMICS
- Exploring Uncertainty in Cost-Effectiveness Analysis
- (2008) Karl Claxton PHARMACOECONOMICS
- Welfarism, extra-welfarism and capability: The spread of ideas in health economics
- (2008) Joanna Coast et al. SOCIAL SCIENCE & MEDICINE
- Welfarism vs. extra-welfarism
- (2007) Werner B.F. Brouwer et al. JOURNAL OF HEALTH ECONOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started